Clinical Trials Directory

Trials / Unknown

UnknownNCT04052750

SMS Reminders and Treatment Compliance and Efficacy in Patients With FGIDs

Daily Short Message Service Reminders Increase Treatment Compliance and Efficacy in Outpatients With Functional Gastrointestinal Disorders: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
176 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The effect of SMS follow-up on drug compliance and efficacy in patients with FGIDs has not been reported in the literature. We, therefore, conducted a prospective randomized controlled trial to investigate whether SMS follow-up could improve treatment adherence in patients with FGIDs, which in turn would help symptom relief and improve treatment outcomes.

Detailed description

The irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs) are common and pose significant burdens to patients. Although regular medications have substantial benefits for disease remission, many patients do not follow the recommendations of standard medication regimens given by physicians at the time of the visit, so how to improve patient compliance becomes even more important. Many factors can affect drug compliance. Forgetting seems to be one of the important reasons for poor compliance. In order to solve this problem, many studies such as drug charts/calendars, mini kits, etc. have been conducted in previous studies. At present, with the popularization of mobile phones, SMS-based interventions are gradually being applied to various medical environments. Compared with the phone, SMS consumes less time and can be easily integrated into the patient's daily life. Therefore, short messages may be more suitable for follow-up of patients outside hospital.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSMS follow-upIn addition to conventional treatment, the experimental group received SMS reminding every day until the end of the treatment.

Timeline

Start date
2019-04-30
Primary completion
2020-04-30
Completion
2021-04-30
First posted
2019-08-12
Last updated
2019-08-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04052750. Inclusion in this directory is not an endorsement.